Page 222 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

198 Constantina Yiannakis, Lorna Ward and Matthew David Morgan
[146] Bontscho, J., Schreiber, A., Manz, R. A., et al. Myeloperoxidase-specific plasma cell

depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-
induced glomerulonephritis. J. Am. Soc. Nephrol. 22:336-348.
[147] Haas, M., Eustace, J. A. Immune complex deposits in ANCA-associated crescentic
glomerulonephritis: a study of 126 cases. Kidney Int. 2004; 65:2145-2152.
[148] Chen, M., Xing, G. Q., Yu, F., et al. Complement deposition in renal histopathology of
patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol. Dial.
Transplant. 2009; 24:1247-1252.
[149] Xing, G. Q., Chen, M., Liu, G., et al. Complement activation is involved in renal
damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune
vasculitis. J. Clin. Immunol. 2009; 29:282-291.
[150] Xing, G. Q., Chen, M., Liu, G., et al. Differential Deposition of C4d and MBL in
Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic
Glomerulonephritis. J. Clin. Immunol. 2010; 30:144-156.
[151] Schreiber, A., Xiao, H., Jennette, J. C., et al. C5a receptor mediates neutrophil
activation and ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. 2009; 20:289-
298.
[152] Xiao, H., Schreiber, A., Heeringa, P., et al. Alternative complement pathway in the
pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am. J.
Pathol. 2007; 170:52-64.
[153] Huugen, D., van Esch, A., Xiao, H., et al. Inhibition of complement factor C5 protects
against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney
Int. 2007; 71:646-654.

Complimentary Contributor Copy